Top Story

FDA approves Cresemba for antifungal therapy

March 6, 2015

The FDA has approved Cresemba to treat adults with invasive aspergillosis and invasive mucormycosis.

Cresemba (isavuconazonium sulfate, Astellas Pharma) is the sixth approved antimicrobial product that was designated as a qualified infectious disease product. This status is given to agents meant to treat serious or life-threatening infections under the Generating Antibiotic Incentives Now (GAIN) Act. The FDA also granted isavuconazonium sulfate, available as an oral and intravenous formulation, orphan drug status.

NIH launches study to evaluate community-based HCV therapy

NIH launches study to evaluate community-based HCV therapy

March 6, 2015
The National Institutes of Health, in collaboration with officials in Washington, D.C., have launched the ASCEND Study to determine if the specific type of health care…

CRE outbreak at Cedars-Sinai linked to duodenoscopes

March 6, 2015
Cedars-Sinai Medical Center reported that four patients were infected with carbapenem-resistant Enterobacteriaceae, and 71 patients may have been exposed to the…

Legislation aims to ensure Medicare covers six categories of medications

March 6, 2015
U.S. Sens. Chuck Grassley (R-Iowa) and Sherrod Brown (D-Ohio) introduced legislation this week that would require Medicare prescription drug plans to cover six…
Meeting News Coverage

iPrEx investigators identify predictors of PrEP adherence

March 6, 2015
SEATTLE — Results from the iPrEx open-label extension trial show several key patient characteristics that predicted engagement with pre-exposure prophylaxis…
More News Headlines »
CME
Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

This activity is supported by an educational grant from Alcon Research, LTD.

More »
Meeting News Coverage Video
thumbnail for video 4083453350001

Video: Action needed to reduce CVD risks in HIV patients

February 28, 2015
SEATTLE — Steven Grinspoon, MD, of the Massachusetts General Hospital and Harvard Medical School, gives an…
More »
CME
j526

Regimen Selection in HIV: Considering New Options to Optimize Outcomes

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

More than two decades into the antiretroviral therapy (ART) era, there are numerous options for HIV treatment. The goal…
More »
morganatic-roan
morganatic-roan